Interphex 2007 To Unveil Bio-to-Business Program

Entering its 28th year, Interphex, the world’s largest and most comprehensive pharmaceutical conference and exhibition, will be held at the Jacob K Javits Convention Center in New York from April 24 to 26, 2007.

Some 1,000 leading global companies serving the pharmaceutical and biotechnical industries will showcase the latest lines of equipment, technologies and services in the areas of PharmaManufacturing, PharmaSourcing & Services, PharmaIT and PharmaFacilities.

The producers of Interphex 2007 has introduced a Bio-to-Business program to provide small- and medium-sized biotech companies with the resources to grow their business and scale-up for production.

Bio-to-Business provides an additional avenue for biotech development. It offers a targeted schedule of conference sessions, roundtables, VIP networking opportunities and special events tailored to the needs of this high-growth industry.

The early stages of development represent a critical juncture in the life of a biotechnology company; process development, regulatory strategy, and selection of sourcing and manufacturing partners are all crucial considerations.

“The Bio-to-Business program provides a balance of education, networking and sourcing opportunities. Biotechnology company executives will uncover technologies to speed development, gain regulatory insight, and network with potential investors to help realize full-scale production and commercialization of new drugs,” says RJ Palermo, event director at Reed Exhibitions."

Bio-to-Business provides select programming for all three days, including a series of specially-selected conference sessions on topics, such as PAT, process development and disposable technologies.

The event is capped with a special event and panel discussion on the topic of funding for early stage life sciences companies, which will be moderated by Life Sciences Greenhouse of Central Pennsylvania (LSGPA).

The panel will be comprised of entrepreneurs, venture capitalists, angel investors and federal funding sources, such as the National Institutes of Health. Speakers will discuss the various types of funding available to biotechnology start ups, when each type is appropriate, and strategies for establishing relationships with venture capitalists and other financial sources.

Interphex 2007 will be co-located with PharmaMedDevice Conference and Exhibition, the world’s first inclusive forum for the converging medical device, pharmaceutical and biologic industries.